The article, prepared based on a report presented at a scientific session of the general meeting of RAS members, is devoted to topical issues of the development of biomedical neurotechnologies in Russian Federation. The authors draw attention to the main directions, points of growth and the unique experience of the interdisciplinary and integrated approach of the Federal Medical Biological Agency and its research centers in solving fundamental and applied problems in the field of neuroscience, the development of innovative medicines, technologies for the treatment of diseases of the nervous system and neurorehabilitation.
No takes yet. Share an insight, caveat, or question.
Скворцова et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: